| Record ID | marc_columbia/Columbia-extract-20221130-007.mrc:480528576:1284 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-007.mrc:480528576:1284?format=raw |
LEADER: 01284cam a2200325 i 4500
001 3481250
005 20221020080400.0
008 790711s1978 dcu b f000 0 eng
010 $a 79600624
020 $c$3.75 (pbk. :)
035 $a(OCoLC)ocm05262988
035 $9AJG7383DC
035 $a3481250
037 $b20402
040 $aDLC$cDLC$dGPO$dMvI
043 $an-us---
074 $a535
082 0 $a343/.73/08556151
086 0 $aFT 1.2:D 84/3
099 $aFT 1.2:D 84/3
100 1 $aFitzpatrick, Roger J.$0http://id.loc.gov/authorities/names/n79020025
245 10 $aAdvertising for over-the-counter drugs :$bpublic record 215-51, 16 CFR part 450 : report of the presiding officer on proposed trade regulation rule /$cRoger J. Fitzpatrick.
260 $a[Washington] :$bFederal Trade Commission : for sale by the Supt. of Docs., U.S. Govt. Print. Off.,$c1978.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references.
650 0 $aAdvertising$xPharmaceutical industry$xLaw and legislation$zUnited States.
650 0 $aDrugs, Nonprescription$zUnited States.
710 1 $aUnited States.$bFederal Trade Commission.$0http://id.loc.gov/authorities/names/n79066322
852 30 $boff,docs$hFT 1.2:D 84/3